SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  June 2025 of Rs. 56019.60 millions grew by 24.54 % from Rs. 44980.70 millions.The company almost doubled its revenue to Rs. 7535.30 millions  from Rs. 2378.20 millions in the quarter ended June 2025.The company reported a good operating profit of 19948.40 millions compared to 8438.10 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 56019.60 44980.70 24.54 56019.60 44980.70 24.54 230033.30 202751.70 13.46
Other Income 2932.10 827.40 254.38 2932.10 827.40 254.38 6239.70 4657.60 33.97
PBIDT 19948.40 8438.10 136.41 19948.40 8438.10 136.41 71620.50 60533.70 18.32
Interest 2232.90 2160.80 3.34 2232.90 2160.80 3.34 8932.10 7840.80 13.92
PBDT 14839.10 6277.30 136.39 14839.10 6277.30 136.39 62688.40 50502.70 24.13
Depreciation 2990.30 3698.10 -19.14 2990.30 3698.10 -19.14 12382.70 16006.20 -22.64
PBT 11848.80 2579.20 359.40 11848.80 2579.20 359.40 50305.70 34496.50 45.83
TAX 4313.50 201.00 2046.02 4313.50 201.00 2046.02 7479.50 5914.70 26.46
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7535.30 2378.20 216.85 7535.30 2378.20 216.85 42826.20 28581.80 49.84
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 35.61 18.76 89.82 35.61 18.76 89.82 31.13 29.86 4.28

Sun Pharma Inds. Share Price

1673.90 -1.30 (-0.08%)
20-Apr-2026 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.90
Dr. Reddys Lab 1237.60
Cipla 1237.10
Zydus Lifesciences 941.00
Lupin 2328.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×